| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.6 | 0.0003 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.45 | 0.0005 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |